Lipocine Inc. (LPCN) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Lipocine Inc. (LPCN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $13.2M, listed on NASDAQ, employing roughly 16 people, carrying a beta of 0.50 to the broader market. Lipocine Inc. Led by Mahesh V. Patel, public since 2013-10-22.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for LPCN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.